Neuroendocrine cancer can manifest itself as many small tumours in a cluster in the small intestine.

New research shows that, surprisingly, these tumours originate from different cells that have mutated independently. The finding that the tumours are not related, which has been published in Nature Communications, came about through a close collaboration among clinical and basic science researchers at the University of Gothenburg and Sahlgrenska University Hospital.

Neuroendocrine cancer of the small intestine is a relatively rare cancer, affecting a few hundred people in Sweden every year. At the same time, it is the most common form of cancer of the small intestine. The disease is also called SI-NET (Small Intestine Neuroendocrine Tumour).

Because the cancer grows slowly, patients can live with the disease for a long time.

Concrete clinical question

“When we remove neuroendocrine tumours in the small intestine, we often find many tumours in the same place, which is unusual. No other cancer really looks like this,” says Erik Elias, an endocrine surgeon at Sahlgrenska University Hospital and a post-doctoral researcher at the University of Gothenburg.

“The cancer is also unusual because known driver mutations are largely absent.”

Elias asked Erik Larsson Lekholm, a professor of bioinformatics at the University of Gothenburg, to join him in searching for answers to the question of how the tumour clusters form. They emphasise that their collaboration is largely translational in nature, where bioinformatic analyses in state-of-the-art research have been applied to a concrete question from everyday life in the clinic.

The researchers began by mapping complete genome sequences from 11 tumours and metastases found in a single patient. By comparing non-driver mutations (known as passenger mutations) in the different tumours, they could map their family trees.

Surprising answer

The result was both unambiguous and surprising. The intestinal tumours had developed independently. Yet the metastases were clearly related and could be traced back to a specific bowel tumour.

”Usually we think that cancer emanates from a single cell, where the balance in cell division has been disrupted due to genetic changes,” says Erik Larsson Lekholm, who believes the finding opens the door to a new field of research.

“Tumour development then occurs in stages. In the worst case, it can eventually lead to metastatic cancer, which can spread both locally and to other places in the body. In this case, the process has been started not just once, but several times in the same tissue.

“What can actually account for this? How can several different cells in roughly the same place in the body simultaneously develop similar cancer properties, and without obvious driving mutations? Our hypothesis is that there may have been a change in the environment in which the cells are located, and we have begun to investigate this further.”

Great clinical significance

After the first surprising result, the whole genome sequencing of tumours, metastases, and blood from another ten patients was repeated, partly using material from a local biobank that has been built up over many years through a collaboration between endocrine surgery and pathology at Sahlgrenska University Hospital. Arman Ardalan, a post-doctoral researcher in bioinformatics in Larsson Lekholm’s team, has done an important job with the data analysis.

All tumours need to be removed

In addition to the finding that the tumours evolved independently, the study provides another surprising insight: often not just one, but several of these tumours give rise to metastases. For surgeon Erik Elias, the discovery has great clinical relevance:

“This study underscores the importance of removing all tumours in the intestine. In surgical care, we need to discuss whether we should use greater margins when operating, removing more bowel so that we can be more confident we have removed all bowel tumours. It is quite possible that the late relapses in the disease that we unfortunately sometimes see can be prevented by such a measure. Obviously, this would be of great importance for the individual patient.”

Source: University of Gothenburg